New BMS Japan Boots Up with Richer Cancer Assets as Celgene Merger Closes

July 1, 2021
Jean-Christophe Barland, President and CEO, Bristol-Myers Squibb K.K. Over one and a half years after its global merger, Bristol Myers Squibb will finally wrap up its integration with Celgene in Japan on July 1, creating a biopharma powerhouse that boasts...read more